<ARTICLE> 5 <LEGEND> This schedule contains summary information extracted from Intel Corporation's CONSOLIDATED CONDENSED STATEMENTS OF INCOME AND CONSOLIDATED BALANCE SHEETS and is qualified in its entirety by reference to such financial statements. </LEGEND> <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> DEC-28-1996 <PERIOD-END> JUN-29-1996 <CASH> 2809 <SECURITIES> 1906 <RECEIVABLES> 2900<F3> <ALLOWANCES> 0 <INVENTORY> 1479 <CURRENT-ASSETS> 9624 <PP&E> 13216 <DEPRECIATION> 5074 <TOTAL-ASSETS> 19300 <CURRENT-LIABILITIES> 3513 <BONDS> 399 <PREFERRED-MANDATORY> 750<F1> <PREFERRED> 0 <COMMON> 2748 <OTHER-SE> 0 <TOTAL-LIABILITY-AND-EQUITY> 19300 <SALES> 9265 <TOTAL-REVENUES> 9265 <CGS> 4571 <TOTAL-COSTS> 4571 <OTHER-EXPENSES> 839<F2> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 8 <INCOME-PRETAX> 2977 <INCOME-TAX> 1042 <INCOME-CONTINUING> 1935 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 1935 <EPS-PRIMARY> 2.19 <EPS-DILUTED> 0 <FN> <F1>Item consists of put warrants. <F2>Item consists of research and development. <F3>Item shown net of allowance, consistent with the balance sheet presentation. </FN>